Tech Company Financing Transactions
Rome Therapeutics Funding Round
Rome Therapeutics closed a $77 million Series B financing round on 9/15/2021. Investors included Section 32, Alexandria Venture Investments and Andreessen Horowitz.
Transaction Overview
Section 32 (Lead Investor) (Steven Kafka)
Alexandria Venture Investments
Mass General Brigham Innovation
Sanofi-Genzyme BioVentures (James Trenkle)
Company Information
Cambridge, MA 02139
USA
Management Team
Browse more venture capital transactions:
Prev: 9/15/2021: CreatorIQ venture capital transaction
Next: 9/15/2021: Ambi Robotics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs